Search our Current Studies
This phase 3 study is evaluating the efficacy and safety of study TQJ230 compared to placebo in the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a).
Location(s): Jacksonville (Headquarters), St. Augustine
Condition: Heart Disease
The purpose of this phase 3 study is to evaluate the effect of finerenone compared to placebo in the reduction of cardiovascular death and total Heart Failure events, including HF hospitalization and urgent visits for HF in patients suffering from HF with an ejection fraction greater than or equal to 40%.
Location(s): St. Augustine
Condition: Heart Failure
The purpose of this phase 2 study is to evaluate the bleeding profile of abelacimab compared to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.
Location(s): Jacksonville (Headquarters), St. Augustine
Condition: Atrial Fibrillation, Heart Disease
The purpose of this phase 3 study is to evaluate the safety and effects of study tirzepatide on body weight compared to placebo T2DM patients who are overweight or obese.
Location(s): Macon
Condition: Diabetes, Obese/Obesity
The purpose of the study is to evaluate the dose-response efficacy, safety, and pharmacokinetics (PK) of AZD5718 compared to placebo in participants with proteinuric chronic kidney disease (CKD).
Location(s): Macon
Condition: Kidney Disease
This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.
Location(s): Jacksonville- LaVilla (Downtown), Lake CIty, Macon
Condition: Diabetic Peripheral Neuropathy
This is a randomized, double-blind, placebo-controlled Phase 2 study to evaluate the efficacy and safety of drug IONIS-AGT-LRx compared to placebo in patients with treatment-resistant hypertension (rHTN).
Location(s): Jacksonville (Headquarters), St. Augustine
Condition: Resistant Hypertension
This is a phase 2 study evaluating drug LY3437943 safety and effectiveness compared to placebo in subjects who are overweight or obese patients.
Location(s): Jacksonville (Headquarters)
Condition: Overweight/Obesity
The purpose of this study is to evaluate the effectiveness of 2 doses or 3 doses of GSK’s licenced meningococcal group B Bexsero (rMenB+OMV NZ) vaccine and of 2 doses of GSK’s investigational combined meningococcal (MenABCWY) vaccine (GSK3536819A) in healthy adolescents and young adults.
Location(s): Lake CIty
Condition: Vaccine
This study compares insulin icodec (a new insulin taken once a week) to insulin glargine (an insulin taken once daily which is already available on the market) in people with type 2 diabetes.
Location(s): Jacksonville (Headquarters)
Condition: Diabetes
This is a randomized, double-blind, placebo-controlled, dose-ranging Phase 2 study to evaluate the efficacy and safety of drug CIN-107 compared to placebo in patients with treatment-resistant hypertension (rHTN). The study will assess three oral doses of CIN-107 versus placebo.
Location(s): Jacksonville (Headquarters)
Condition: Resistant Hypertension
This study is evaluating the InterStim Micro system performance and safety to confirm long term outcomes
Location(s): Jacksonville (Headquarters)
Condition: Fecal Incontinence, Non-obstructive Urinary Retention, Overactive Bladder
This is a Phase 2a study being done to evaluate the efficacy, safety, PK, and immunogenicity of multiple doses of MEDI3506 in adult subjects with DKD.
Location(s): Jacksonville- LaVilla (Downtown)
Condition:
This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.
Location(s): Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes, Heart Disease
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine
Condition: Cholesterol, Heart Disease
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes